What is he best known for?
The fields of study he is best known for:
Molecular biology, Cell biology, Immunology, Cancer research and Angiogenesis are his primary areas of study.
His Molecular biology study incorporates themes from HIV Long Terminal Repeat, Acetylation, DNA and Transcription, Transactivation.
The various areas that Mauro Giacca examines in his Cell biology study include Cell cycle, Internalization, Endocytosis and Cell growth.
His research in Immunology intersects with topics in Peripheral blood mononuclear cell and Virology.
Mauro Giacca works mostly in the field of Cancer research, limiting it down to topics relating to Genetic enhancement and, in certain cases, microRNA, Heart failure, Myocardial infarction, Myocyte and Wound healing, as a part of the same area of interest.
Mauro Giacca combines subjects such as Semaphorin, Tumor hypoxia, Vascular endothelial growth factor and Myeloid with his study of Angiogenesis.
His most cited work include:
- Functional screening identifies miRNAs inducing cardiac regeneration (678 citations)
- Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels (668 citations)
- Internalization of HIV-1 Tat Requires Cell Surface Heparan Sulfate Proteoglycans (622 citations)
What are the main themes of his work throughout his whole career to date?
Mauro Giacca mainly focuses on Cell biology, Molecular biology, Internal medicine, Genetic enhancement and Immunology.
His work deals with themes such as Cell cycle, microRNA and Transcription, which intersect with Cell biology.
His studies deal with areas such as Polymerase chain reaction, Gene, DNA, DNA replication and Transactivation as well as Molecular biology.
His Internal medicine research is multidisciplinary, relying on both Endocrinology and Cardiology.
His Immunology research includes themes of Cancer research and Virology.
His biological study spans a wide range of topics, including Vascular endothelial growth factor A and Pathology.
He most often published in these fields:
- Cell biology (38.89%)
- Molecular biology (22.73%)
- Internal medicine (18.01%)
What were the highlights of his more recent work (between 2017-2021)?
- Cell biology (38.89%)
- Heart failure (12.12%)
- microRNA (11.11%)
In recent papers he was focusing on the following fields of study:
Cell biology, Heart failure, microRNA, Internal medicine and Myocardial infarction are his primary areas of study.
His work carried out in the field of Cell biology brings together such families of science as Embryonic stem cell, Non-coding RNA and Transcription factor.
His microRNA research is multidisciplinary, incorporating elements of Regulator, Cancer research, Genetic enhancement and Poorly differentiated.
His research investigates the connection between Genetic enhancement and topics such as Cell type that intersect with problems in Cancer cell.
His Internal medicine study combines topics in areas such as Endocrinology, Oncology and Cardiology.
His Myocardial infarction research includes elements of Cardiac function curve, Angiogenesis, Contractility and Bioinformatics.
Between 2017 and 2021, his most popular works were:
- MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs (110 citations)
- MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs (110 citations)
- MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs (110 citations)
In his most recent research, the most cited papers focused on:
His scientific interests lie mostly in Cell biology, Heart failure, Disease, Myocyte and microRNA.
He studies Hippo signaling pathway which is a part of Cell biology.
His Heart failure research incorporates elements of SIRT3 and Function.
His research integrates issues of Syncytium, Lung and Heart development in his study of Disease.
Mauro Giacca has included themes like Paracrine signalling, Cellular differentiation, Cardiac function curve, Myocardial infarction and Contractility in his Myocyte study.
His microRNA study deals with Genetic enhancement intersecting with Embryonic stem cell, Non-coding RNA, Cancer cell, RNA and Cell cycle.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
